Following expanded FDA approval for pediatric patients, the over-the-counter Stelo continuous glucose monitor is adding AI ...

AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...

Compare the Apple Watch, Samsung Galaxy Watch, and Pixel Watch for blood sugar tracking, CGM alerts, health trends, battery ...

Every day there are new posts in a Facebook group — 89.5 thousand members strong — dedicated to Dexcom G7 issues and complaints. From inaccurate CGM readings and sensor failures to frustrating ...

Dexcom received FDA clearance for its first over-the-counter continuous glucose monitor, called Stelo. The device is intended for people with Type 2 diabetes who do not take insulin. · MedTech Dive · ...

CONTINUOUS GLUCOSE MONITORS are an important tool for people with diabetes. But if you recently bought a Dexcom continuous glucose monitor, you might want to double-check the label. You may be wearing ...

Dexcom says stolen G7 sensors from two scrapped lots were sold through unauthorized channels, creating infection and reading-failure risks. Medical device maker Dexcom says two lots of its Dexcom G7 ...

Dexcom warned that some lots of its G7 wearable glucose monitors were stolen on their way to the scrapyard and were sold by a third-party vendor. (Dexcom) Dexcom warned that some lots of its G7 ...

Editor's note: This article has been updated with a comment from a Pharmsource spokesperson. Continuous glucose monitoring specialist Dexcom has identified two lots of Dexcom G7 sensors (1725204004 ...

May 26 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab said on Tuesday some of its glucose sensors slated for destruction were instead stolen and ‌sold, prompting the company to warn ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

During glucose-monitoring specialist Dexcom's Investor Day on Thursday, CEO Jake Leach announced the release of its Dexcom G8 continuous glucose monitor, which Leach describes as a "completely new ...